Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease

NCT01560585 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class

Stopped Adverse events in 2/3 participants; study was halted but not restarted after this due to insufficnet funds as well

Conditions

Interventions

Sponsor

University Hospitals Cleveland Medical Center